Viewing Study NCT02686658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-02-20 @ 6:46 PM
Study NCT ID: NCT02686658
Status: COMPLETED
Last Update Posted: 2025-06-10
First Post: 2016-02-16
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Sponsor: IVERIC bio, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Geographic Atrophy View
None Dry Age-Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Geographic Atrophy (GA) View
None Dry age-related macular degeneration View
None AMD View
None Zimura (previous name) View
None Anti-inflammatory View
None complement factor C5 inhibitor View
None ARC1905 View
None avacincaptad pegol View